We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN DIEGO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from...
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.39 | 13 | 3 | 3.3992 | 2.98 | 930482 | 3.10605539 | CS |
4 | 0.42 | 14.1414141414 | 2.97 | 3.78 | 2.965 | 777546 | 3.23959991 | CS |
12 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.68 | 1017505 | 2.90822361 | CS |
26 | 1.69 | 99.4117647059 | 1.7 | 3.8001 | 1.42 | 672920 | 2.58200514 | CS |
52 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.42 | 651367 | 2.55173036 | CS |
156 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.42 | 651367 | 2.55173036 | CS |
260 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.42 | 651367 | 2.55173036 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions